Literature DB >> 6196076

Prospective study of follow up alone in stage I teratoma of the testis.

G Read, R J Johnson, P M Wilkinson, B Eddleston.   

Abstract

In a prospective surveillance study of 45 patients with stage I teratoma of the testis 34 (76%) required no further treatment. Eleven patients relapsed but were salvaged by chemotherapy and radiotherapy. Seven patients relapsed within three months of the initial assessment and only one after more than 12 months. These preliminary results suggest that a follow up policy in stage I teratoma of the testis is possible but only in a regional centre with facilities for close monitoring of patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196076      PMCID: PMC1549955          DOI: 10.1136/bmj.287.6404.1503

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  6 in total

1.  The role of computed tomography in the management of testicular teratoma.

Authors:  J E Husband; M J Peckham; J S Macdonald; W F Hendry
Journal:  Clin Radiol       Date:  1979-05       Impact factor: 2.350

2.  Orchidectomy alone for stage I testicular teratoma.

Authors:  R Stout; R D Hunter
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-03

3.  Computed tomography (CT) in the staging of patients with Hodgkin's Disease: a report on 136 patients.

Authors:  G Blackledge; J J Best; D Crowther; I Isherwood
Journal:  Clin Radiol       Date:  1980-03       Impact factor: 2.350

4.  Radiotherapy for patients with tumours of the testicle.

Authors:  D Smithers; E N Wallace; D M Wallace
Journal:  Br J Urol       Date:  1971-02

5.  Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours.

Authors:  M J Peckham; A Barrett; J E Husband; W F Hendry
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

6.  Lymphomas of the testis-results of treatment 1960-77.

Authors:  G Read
Journal:  Clin Radiol       Date:  1981-11       Impact factor: 2.350

  6 in total
  7 in total

1.  Canadian consensus guidelines for the management of testicular germ cell cancer.

Authors:  Lori Wood; Christian Kollmannsberger; Michael Jewett; Peter Chung; Sebastian Hotte; Martin O'Malley; Joan Sweet; Lynn Anson-Cartwright; Eric Winquist; Scott North; Scott Tyldesley; Jeremy Sturgeon; Mary Gospodarowicz; Roanne Segal; Tina Cheng; Peter Venner; Malcolm Moore; Peter Albers; Robert Huddart; Craig Nichols; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

2.  Chemotherapy for non-seminomatous germ-cell tumours.

Authors:  P M Wilkinson
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

3.  Carcinoma in situ of the contralateral testis.

Authors:  G Read
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-10

4.  Factors contributing to delay in diagnosis of testicular tumours.

Authors:  R T Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-02

5.  Value of follow up in testicular cancer.

Authors:  G Read; R J Johnson; B Eddleston
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12

6.  The role of radiotherapy after chemotherapy in the management of persistent para-aortic nodal disease in non-seminomatous germ cell tumours.

Authors:  G Read; R J Johnson; P M Wilkinson
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

7.  The management of testicular seminoma: Edinburgh 1970-1981.

Authors:  W Duncan; A J Munro
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.